Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years

BACKGROUND: How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains unclear. METHODS: A 28-year cohort of 157 PBC patients was conducted. Patients with alkaline phosphatase (Alk-p) level...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ming-Ling, Chen, Wei-Ting, Chan, Tien-Ming, Lin, Cheng-Yu, Chang, Ming-Yu, Chen, Shiang-Chi, Chien, Rong-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160714/
https://www.ncbi.nlm.nih.gov/pubmed/35663951
http://dx.doi.org/10.3389/fimmu.2022.869018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160714/
https://www.ncbi.nlm.nih.gov/pubmed/35663951
http://dx.doi.org/10.3389/fimmu.2022.869018

Ejemplares similares